News
Still no standard for HS, but new options increase chance of control
NEW YORK – Increasing options for hidradenitis suppurativa might be particularly relevant to black patients.
News
Coming acne drugs might particularly benefit skin of color patients
NEW YORK – Because of the slow reversal of postinflammatory hyperpigmentation, it is imperative in skin of color patients to employ therapies with...
News
Recent progress in vitiligo treatment might be heading to vitiligo cure
NEW YORK – Elimination of resident-memory T cells is showing promise for durable vitiligo control.
News
Dermatologists urged to take ownership of preventable AEs
NEW YORK – Dermatologists do not reliably address preventable risks of biologics and glucocorticoids.
News
Midlife hypertension is associated with subsequent risk of dementia
Elevated blood pressure in midlife is associated with risk of subsequent dementia, but whether the risk is treatable is unclear.
News
Criteria found largely interchangeable for classifying radiographic axSpA
Ankylosing spondylitis by modified New York criteria and radiographic axial spondyloarthritis by Assessment of SpondyloArthritis international...
News
Nicotinamide-containing products gaining interest for aging, dermatologic disorders
NEW YORK – Nicotinamide products are being examined in more than 90 active and recruiting trials listed on clinicaltrials.gov.
News
Botulinum toxin injections: Err on the side of undercorrecting in first-time users
NEW YORK – Dermatologists not now offering cosmetic botulinum toxin injections are encouraged to start.
News
Beyond sunscreen: Skin cancer preventive agents finding a role
NEW YORK – A growing list of skin cancer chemopreventive agents is expanding options for risk management.
News
Trained interpreters essential for treating non–English-speaking patients
NEW YORK – Even in a private office setting, failure to engage a trained translator is discouraged.
News
Dermatitis associated with surgical implants merits conservative approach
NEW YORK – Even for persistent allergic dermatitis linked to a prosthetic device, explantation might not be helpful.
News
After prior TNFi in axSpA, taking secukinumab or another TNFi appear equivalent
MADRID – After stopping a prior TNF inhibitor, there was no advantage to switching to the anti–IL-17 biologic secukinumab over a different TNFi...
News
New analysis challenges fluid resuscitation guidelines for patients in shock
For children in shock, fluid resuscitation has counterproductive effects on respiratory and neurologic function.
News
Flurry of new anti–IL-17 monoclonal antibodies show efficacy in axSpA
MADRID – Trial data with three new anti–interleukin-17 receptor monoclonal antibodies in axial spondyloarthritis are positive.
News
Secukinumab reduced joint pain of psoriatic arthritis in early data from phase 3b trial
MADRID – Secukinumab was superior to placebo for the primary endpoint of ASAS20 based on the initial 12-week data...